We recently identified various somatic mutations in exon 2 of the mediator complex subunit 12 (MED12) gene, in as many as 70% of the studied uterine leiomyomas obtained from patients of Finnish (Caucasian) origin [11]. The gene discussed is MED12; the disease is Uterine leiomyoma.